The 19th PACCARB virtual public meeting was focused on global efforts to combat AMR, including updates from the Global Leaders Group (GLG) and the World Health Organization (WHO). The first day also included a presentation from the National Academies on their recent report titled “Examining the Long-term Health and Economic Effects of Antimicrobial Resistance (AMR) in the United States”. The second day included presentations focused on addressing AMR within pandemic preparedness planning, including strengthening public health and agriculture systems, ensuring situational awareness, and transforming medical defenses.
Agenda
Webcast Information
Meeting Documents
Notice
Presentations
Day 1: Global Update on Combating AMR Efforts
Global Leaders Group: Perspectives on Global AMR Efforts (no slides used)
Sally Davies, Global Leaders Group
Perspectives on AMR Priorities (no slides used)
Eric Lander, Science Advisor to the President and Director of the Office of Science and Technology Policy
Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine*
Gillian Buckley, National Academies
WHO: Update on AMR*
Hanan Balkhy, WHO
Codex Alimentarius Report and AMR*
Donald Prater, Food and Drug Administration (FDA)
National Action Plan for Combating Antibiotic-Resistant Bacteria: Progress and Next Steps*
Casey Sullivan, HHS Office of the Assistant Secretary for Planning and Evaluation
The Intersection of Antibiotic Resistance, Antibiotic Use, and COVID-19*
Arjun Srinivasan, Centers for Disease Control and Prevention (CDC)
Day 2: Addressing AMR Within Pandemic Preparedness Planning
Re-Energizing Patient Safety*
Armando Nahum, Patients for Patient Safety, US
Panel 1: Strengthening Public and Agriculture Health Systems & Building Core Capabilities
Healthcare Infection Control Practices Advisory Committee (HICPAC) Activities*
Lisa Maragakis, HICPAC
Defend the Flock Outreach Campaign*
Julie Gauthier, Animal and Plant Health Inspection Service
Impact of Bacterial Infections on Hospitalized COVID-19 Patients*
Mark Albrecht, Biomedical Advanced Research and Development Authority (BARDA)
Fungi, Climate Change, Drug Resistance*
Arturo Casadevall, Johns Hopkins University
Environmental Azole Resistance in Target and Non-Target Fungal Pathogens in Crop Production*
Jim Adaskaveg, University of California, Riverside
Panel 2: Ensuring Situational Awareness
NARMS and the Evolution of One Health Surveillance*
Patrick McDermott, FDA
Action on Data and ARS Systems Approach*
Kim Cook, United States Department of Agriculture (USDA)
Healthcare Surveillance for Emerging and Enduring Threats: CDC’s National Healthcare Safety Network*
Shari Ling, Centers for Medicare & Medicaid Services (CMS) & Arjun Srinivasan, CDC
Panel 3: Transforming Medical Defenses
An Introduction to Project Firstline*
Elizabeth McClune, CDC
AHRQ Safety Program for Improving Antibiotic Use: Development and Implementation of Three National Antibiotic Stewardship Interventions and Toolkits*
Sara Cosgrove, Johns Hopkins University School of Medicine
Catalyzing Antibiotic Development*
Mark Albrecht, BARDA
NIH/NIAID’s Ongoing Role in AMR Initiatives*
Dennis Dixon, National Institutes of Health
*People using assistive technology may not be able to fully access information in these files. For assistance, contact the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria by emailing [email protected].
